Compare MOVE & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOVE | OPK |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 901.4M | 921.2M |
| IPO Year | 2021 | 2011 |
| Metric | MOVE | OPK |
|---|---|---|
| Price | $18.34 | $1.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.60 |
| AVG Volume (30 Days) | 51.2K | ★ 2.1M |
| Earning Date | 04-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $433,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $1,460.71 | N/A |
| Revenue Next Year | $96.77 | $4.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $0.98 |
| 52 Week High | $34.87 | $1.60 |
| Indicator | MOVE | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 59.00 | 48.77 |
| Support Level | $12.44 | $1.12 |
| Resistance Level | $20.04 | $1.15 |
| Average True Range (ATR) | 2.00 | 0.04 |
| MACD | 0.46 | -0.00 |
| Stochastic Oscillator | 64.23 | 76.62 |
Corvex Inc is an AI cloud computing company specializing in GPU accelerated infrastructure for AI workloads. The company provides AI-focused computing infrastructure that offers scalable computational resources. Its platform uses GPU-accelerated compute clusters and high-throughput storage to support performance, security, and efficiency at scale. The company's product portfolio includes GPU Clusters, Inference-as-a-Service, Confidential Computing, and GPU Node.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.